Search

everythinglearnresearchcommunity

for

Search:↓

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib effectively treats Alopecia Areata.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Alopecia areata treatment varies, with no optimal method established yet.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Hair loss in young men in Central India is linked to severe heart disease.

Yellow dots are common in severe alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.